- Joined
- May 13, 2007
- Messages
- 4,352
- Reaction score
- 738
3 Clinics to Pay $2.39M to Settle False Claims Act Allegations re Viscosupplementation:
Three orthopedic clinics will pay a total of $2.39 million to settle federal and state False Claims Act allegations, according toKRCRTV.com.
The involved clinics include:
• Chico-based Orthopedic Associates of Northern California — $815,794
• Redlands, Calif.-based San Bernardino Medical Orthopaedic Group, DBA Arrowhead Orthopaedics — $971,903
• Reno (Nev.) Orthopaedic Clinic — $602,335
Here are five things to know:
1. The three orthopedic clinics allegedly billed federal and state healthcare programs for re-imported osteoarthritis medications, called viscosupplements.
2. Allegedly, the clinics bought discounted viscosupplements that were re-imported from foreign countries. They then billed state and federal healthcare programs for reimbursements, even though the re-imported viscosupplements did not qualify as reimbursable.
3. The federal government claimed that since the products were re-imported, they could have been altered or stored inappropriately.
4. The lawsuit came to fruition after a senior musculoskeletal specialty manger at Sanofi S.A. — a manufacturer of viscosupplements — filed it via the False Claims Act.
5. The court has not yet determined any liability; the settlement is just based on allegations.
http://www.beckersspine.com/orthope...-claims-act-allegations-5-things-to-know.html
Three orthopedic clinics will pay a total of $2.39 million to settle federal and state False Claims Act allegations, according toKRCRTV.com.
The involved clinics include:
• Chico-based Orthopedic Associates of Northern California — $815,794
• Redlands, Calif.-based San Bernardino Medical Orthopaedic Group, DBA Arrowhead Orthopaedics — $971,903
• Reno (Nev.) Orthopaedic Clinic — $602,335
Here are five things to know:
1. The three orthopedic clinics allegedly billed federal and state healthcare programs for re-imported osteoarthritis medications, called viscosupplements.
2. Allegedly, the clinics bought discounted viscosupplements that were re-imported from foreign countries. They then billed state and federal healthcare programs for reimbursements, even though the re-imported viscosupplements did not qualify as reimbursable.
3. The federal government claimed that since the products were re-imported, they could have been altered or stored inappropriately.
4. The lawsuit came to fruition after a senior musculoskeletal specialty manger at Sanofi S.A. — a manufacturer of viscosupplements — filed it via the False Claims Act.
5. The court has not yet determined any liability; the settlement is just based on allegations.
http://www.beckersspine.com/orthope...-claims-act-allegations-5-things-to-know.html
